Hydraderm for Androgenic Alopecia

Inclusion Criteria:

• Participants who can give voluntary, written informed consent to participate in thisstudy and from whom consent has been obtained including HIPAA Authorization

• Participants who have androgenetic alopecia

• Healthy men and women, ages 18 - 65 years of age

• Participants who understand the study and can follow study instructions and arewilling to attend the required study visits

• Participants who agree to be photographed for research purposes and their identitymay not be concealed in these photographs.

• Participants who agree to continue their same treatment they are on at the baselinevisit for androgenetic alopecia, for the entire duration of the study without plansto stop, change or add additional treatments.

• Participants who agree to use the same shampoo for the duration of the study

Exclusion Criteria:

• Participants who have not had a change to hair loss treatment for 4 months prior tostudy enrollment

• Participants who have an active or known skin inflammation or infection within thetreatment area.

• Participants who have an active or known acute skin allergies

• Participants who have any other scalp conditions including eczema, psoriasis,infection, or scars within the treatment area

• Participants of child-bearing potential who are not using an approved method ofbirth control (oral contraceptives, IUD, contraceptive implant, barrier methods withspermicide or abstinence). Females of non-childbearing potential are defined aspost-menopausal (absence of menstrual bleeding for one year), hysterectomy, orbilateral oophorectomy.

• Participants who are pregnant, planning to become pregnant or breastfeeding. A urinepregnancy test will be done to rule out pregnancy.

• Immunosuppression

• Participants who are HIV+ / Hepatitis B + / Hepatitis C+

• Participants who have been diagnosed or have a known history of any hematopathologydisorders

• Participants who have been diagnosed or have a known history of haemostasisdisorders

• Participants who have been diagnosed or have a known history of an autoimmunediseases

• Participants who are undergoing chemotherapy

• Participants with a history of any skin cancer on the scalp

• Participants who have had skin biopsy or procedure on scalp in last month

• Participants who have an implantable devices such as a deep brain stimulator in orother implantable device on or near treatment area

• Non-English speakers